Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 6/20 | 0.51 |
| ▸ | RAD52 | P43351 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | ADRA1A | P35348 | 8/20 | 0.45 |
| ▸ | ADRA1D | P25100 | 7/20 | 0.45 |
| ▸ | ADRA1B | P35368 | 7/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 6/20 | 0.45 |
| ▸ | ADRA2C | P18825 | 6/20 | 0.45 |
| ▸ | HTR1B | P28222 | 5/20 | 0.45 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4993472 | 0.86 | RAD52 (0.49) | HTR1DRAD52TAAR1CYP2D6NFKB1 | |
| SCHEMBL4986340 | 0.85 | RAD52 (0.51) | HTR1DRAD52TAAR1CYP2D6NFKB1 | |
| SCHEMBL29924685 | 0.85 | RAD52 (0.51) | HTR1DRAD52TAAR1CYP2D6NFKB1 | |
| SCHEMBL4997332 | 0.85 | RAD52 (0.51) | HTR1DRAD52TAAR1CYP2D6NFKB1 | |
| SCHEMBL4992620 | 0.85 | ADRA1D (0.49) | HTR1DRAD52TAAR1CYP2D6NFKB1 | |
| SCHEMBL5201043 | 0.84 | HTR1D (0.44) | HTR1DRAD52TAAR1CYP2D6ADRA1A | |
| SCHEMBL5200888 | 0.84 | RAD52 (0.49) | HTR1DRAD52TAAR1CYP2D6NFKB1 | |
| SCHEMBL4994698 | 0.83 | HTR1B (0.51) | HTR1DRAD52TAAR1CYP2D6NFKB1 | |
| Hydrochloric Acid SCHEMBL5200632 | 0.83 | HTR1D (0.43) | HTR1DRAD52TAAR1CYP2D6ADRA1A | |
| SCHEMBL5203427 | 0.83 | RAD52 (0.48) | HTR1DRAD52TAAR1CYP2D6NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040214875-A1 | Imidazolinylmethyl aralkylsulfonamides | ROCHE PALO ALTO LLC | 2004-10-28 | — | — | US | claimed |
| US-6756395-B2 | CYCLIZATION OF N-(4-CYANOMETHYLPHENYL)METHANESULFONAMIDES WITH ETHYLENEDIAMINE TO FORM N-(4-IMIDAZOL-2-YLMETHYL)-PHENYL) -METHANESULFONAMIDES; INCONTINENCE, SEXUAL DYSFUNCTION, NASAL CONGESTION, AND CNS DISORDERS; ALPHA 1 ADRENERGIC AGONISTS | ROCHE PALO ALTO LLC | 2004-06-29 | — | — | US | claimed |
| US-7407980-B2 | Imidazolinylmethyl aralkylsulfonamides | ROCHE PALO ALTO LLC (US) | 2008-08-05 | — | — | US | disclosed |
| US-7407980-B2 | Imidazolinylmethyl aralkylsulfonamides | ROCHE PALO ALTO LLC (US) | 2008-08-05 | — | — | US | disclosed |
| US-7407980-B2 | Imidazolinylmethyl aralkylsulfonamides | ROCHE PALO ALTO LLC (US) | 2008-08-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214875-A1 | Imidazolinylmethyl aralkylsulfonamides | RPS6KA1, RPS6KB1, RPS6KA6 | HTR1D 3255/4885RAD52 1971/4885TAAR1 3937/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.